Significant association between lower pulse pressure and increasing levels of a novel type of phospholipid.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Genetics and Molecular Research

• Publication date

  2014-02-21

• Fields of study

  Medicine

• Identifiers
  DOI 10.4238/2014.February.21.16PMID 24634302
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Relation of pulse pressure and arterial stiffness to concentric left ventricular hypertrophy in young men (from the Bogalusa Heart Study).

  2009cited by this paper
• Autotaxin/Lysopholipase D and Lysophosphatidic Acid Regulate Murine Hemostasis and Thrombosis*

  2009cited by this paper
• Low pulse pressure is an independent predictor of mortality and morbidity in non ischaemic, but not in ischaemic advanced heart failure patients.

  2009cited by this paper
• Roles of lysophosphatidic acid in cardiovascular physiology and disease.

  2008cited by this paper
• Determinants of increasing pulse pressure during 23 years' follow‐up as a marker of arterial stiffness and vascular ageing

  2008cited by this paper
• Physiology and disease.

  2008cited by this paper
• Lysophosphatidic acid-induced platelet shape change revealed through LPA1–5 receptor-selective probes and albumin

  2008cited by this paper
• Ischemic preconditioning upregulates expression of phospholipase D2 in the rat hippocampus

  2007cited by this paper
• Low pulse pressure is independently related to elevated natriuretic peptides and increased mortality in advanced chronic heart failure.

  2005cited by this paper
• The plaque lipid lysophosphatidic acid stimulates platelet activation and platelet-monocyte aggregate formation in whole blood: involvement of P2Y1 and P2Y12 receptors.

  2004cited by this paper
• Introduction to surrogate markers.

  2004cited by this paper
• Subtype-Selective Antagonists of Lysophosphatidic Acid Receptors Inhibit Platelet Activation Triggered by the Lipid Core of Atherosclerotic Plaques

  2003cited by this paper
• Potential role of lysophosphatidic acid in hypertension and atherosclerosis.

  2003cited by this paper
• Hypertension, angiotensin II, and oxidative stress.

  2002cited by this paper
• Direct quantitative analysis of lysophosphatidic acid molecular species by stable isotope dilution electrospray ionization liquid chromatography-mass spectrometry.

  2001cited by this paper
• Involvement of ERK and p38 MAP kinase in oxidative stress-induced phospholipase D activation in PC12 cells

  2001cited by this paper
• Implications of Pulse Pressure as a Predictor of Cardiac Risk in Patients With Hypertension

  2000cited by this paper
• Pulse pressure as a risk factor for cardiovascular events in the MRC Mild Hypertension Trial.

  1999cited by this paper
• Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study.

  1999cited by this paper
• Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions.

  1999cited by this paper
• Ambulatory pulse pressure: a potent predictor of total cardiovascular risk in hypertension.

  1998cited by this paper
• Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population.

  1997cited by this paper
• Hydrogen Peroxide‐Induced Phospholipase D Activation in Rat Pheochromocytoma PC12 Cells: Possible Involvement of Ca2+‐Dependent Protein Tyrosine Kinase

  1997cited by this paper
• The bioactive phospholipid lysophosphatidic acid is released from activated platelets.

  1993cited by this paper
• Identification of the molecular species of lysophosphatidic acid produced when platelets are stimulated by thrombin.

  1989cited by this paper
• Degradation of phospholipid molecular species during experimental cerebral ischemia in rats.

  1988cited by this paper
• A comparison of extraction methods for the isolation of phospholipids from biological sources.

  1986cited by this paper

• LPA-Induced Thromboxane A2-Mediated Vasoconstriction Is Limited to Poly-Unsaturated Molecular Species in Mouse Aortas

  2024cites this paper
• Chronic isolated lightheadedness is a sign of abnormal plasma levels of phospholipids.

  2021cites this paper
• Molecular mechanism of lysophosphatidic acid-induced hypertensive response

  2019cites this paper
• Genetic and Functional Evidence Supports LPAR1 as a Susceptibility Gene for Hypertension

  2015cites this paper